Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin

Affiliations

• ¹ Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK. kiran.batta@manchester.ac.uk.
• ² Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK.
• ³ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁴ Haematological Malignancies Biobank, Manchester Cancer Research Centre, The University of Manchester, Manchester, UK.
• ⁵ Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.
• ⁶ Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK.
• ⁷ Northern Centre for Cancer Care, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.
• ⁸ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁹ Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
• ¹⁰ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
• ¹¹ Haematological Malignancy Diagnostics Service, St James' University Hospital, Leeds, UK.
• ¹² Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
• ¹³ Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK. daniel.wiseman@manchester.ac.uk.
• ¹⁴ Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK. daniel.wiseman@manchester.ac.uk.